Abstract
Lentigo maligna and lentigo maligna melanoma represent a characteristic, histogenetic subclass of melanocytic malignancies. They are found on chronically light-exposed skin, usually the face of middle-aged and elderly people. During the long preinvasive period, called lentigo maligna, a very slow horizontal growth can be observed. After a variable period of time, invasion into the underlying dermis will occur. Other names for the preceding horizontal or in-situ growth phase are Hutchinson’s melanotic freckle and premalignant melanosis of Dubreuilh. Once obvious dermal invasion is present, the name lentigo maligna melanoma is appropriate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Arlette JP, Trotter MJ, Trotter T, Temple CL. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology. J Surg Oncol 2004; 86:179–186
Schiffner R, Schiffner-Rohe J, Vogt T, et al. Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol 2000; 42:25–32
Stolz W, Braun-Falco O, Bilek P, Burgdorf WHC, Landthaler M. Colour atlas of dermatoscopy, 2nd edn. Blackwell, London, 2002
Mahendran R, Newton-Bishop JA. Survey of UK current practice in the treatment of lentigo maligna. Br J Dermatol 2001; 144:71–76
National Institute of Health Consensus Conference. Diagnosis and treatment of early melanoma. NIH Consensus development panel on early melanoma. J Am Med Assoc 1992; 268:1314–1319
Balch CM, Soong S, Smith T, et al. Long-term results of a prospective surgical trial comparing 2cm vs 4cm excision with margins for intermediate-thickness melanomas. Ann Surg Oncol 2001; 8:101–108
Bub JL, Berg D, Slee A, et al. Management of lentigo maligna nd lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol 2004; 140:552–558
Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna melanoma: a follow-up study. Dermatol Surg 1998; 24:673–677
Collins P, Rogers S, Goggin M, et al. Cryotherapy of lentigo maligna. Clin Exp Dermatol 1991; 16:433–435
Farshad A, Burg G, Panizzon R, et al. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol 2002; 146:1042–1046
Prieto MAR, Lopez PM, Gonzalez IR, et al. Treatment of lentigo maligna with azelaic acid. Int J Dermatol 1993; 32:353–364
Doherty VR. Azelaic acid in lentigo maligna. Br J Dermatol 1987; 116:606
Iyer S, Goldman M. Treatment of lentigo maligna with combination laser therapy: recurrence at 8 months after initial resolution. J Cosmet Laser Ther 2003; 5:49–52
Ahmed I, Berth-Jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol 2000; 143:843–845
Naylor MF, Crowson N, Kuwahara R, et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 2003; 149 (Suppl):66–70
Powell AM, Russell-Jones R, Barlow RJ. Topical imiquimod immunotherapy in the management of lentigo maligna. Clin Exp Dermatol 2004; 29:15–21
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2007). Melanoma of the Face. In: Soyer, H., Argenziano, G., Hofmann-Wellenhof, R., Johr, R. (eds) Color Atlas of Melanocytic Lesions of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35106-1_34
Download citation
DOI: https://doi.org/10.1007/978-3-540-35106-1_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-35105-4
Online ISBN: 978-3-540-35106-1
eBook Packages: MedicineMedicine (R0)